Clog-Free, Low-Cost, and Uniform Electrode Inks for 3D Printed Lithium-Ion Batteries by Shengqi Ao (12871910)

“…Here, a series of clog-free printable electrode inks for LIBs are developed by a practical and universal approach with multiple ball-milled processes. …”

Clog-Free, Low-Cost, and Uniform Electrode Inks for 3D Printed Lithium-Ion Batteries by Shengqi Ao (12871910)

“…Here, a series of clog-free printable electrode inks for LIBs are developed by a practical and universal approach with multiple ball-milled processes. …”

Clog-Free, Low-Cost, and Uniform Electrode Inks for 3D Printed Lithium-Ion Batteries by Shengqi Ao (12871910)

“…Here, a series of clog-free printable electrode inks for LIBs are developed by a practical and universal approach with multiple ball-milled processes. …”

Clog-Free, Low-Cost, and Uniform Electrode Inks for 3D Printed Lithium-Ion Batteries by Shengqi Ao (12871910)

“…Here, a series of clog-free printable electrode inks for LIBs are developed by a practical and universal approach with multiple ball-milled processes. …”

Impaired elastin deposition in E18.5 <i>Fstl1^−/−</i> lungs and D7 <i>Fstl1^−/−</i> lung allografts. by Yan Geng (268097)

“…(E) Elastin production was decreased in E18.5 <i>Fstl1^−/−</i> lungs using qRT-PCR analysis (n = 6). …”

S1 Data - by Ming-Jun Chen (579568)

“…Within the range of 50–744 pmol/L, each 100 pmol/L increase in CysC was associated with a 37% decrease in the odds of sarcopenia (odds ratio [OR], 0.63; 95% confidence interval [CI], 0.49 to 0.83; P < 0.001). …”

Controlling Symmetry Breaking Charge Transfer in BODIPY Pairs by Laura Estergreen (1355682)

Daily and seasonal changes of vocal activity of the Common Crane <i>Grus grus</i>: implications for conservation and monitoring efforts by Michał Budka (608553)

“…Reducing survey duration from 1 h to 10 min caused a decrease of detection to 0.29 in March and 0.13 in April and May.…”

Immunofluorescence of non-infected DH82 cells and persistently CDV-Ond infected DH82 cells 1 day post seeding using anti-CDV nucleoprotein and anti-cleaved caspase 3 antibodies. by Vanessa Maria Pfankuche (3375392)

Minocycline administration ameliorates photoreceptor cell death in <i>Mertk</i>^−/−<i>Cx3cr1</i>^<i>GFP/+</i><i>Ccr2</i>^<i>RFP/+</i> mice. by Ryo Terauchi (10687481)

Shows the relation between esteem, disesteem and the proportion of a population that complies with a specific behavioural practice. by Jibonayan Raychaudhuri (17549817)

“…As the proportion of the compliers increases from <i>A</i> to <i>B</i>, the esteem obtained from it decreases. …”

Structural components of transmission networks across the lockdown. by Matteo Serafino (11599593)

Dendritic arborization defects caused by MCAO in M1 are completely reverted during the days after the ischemic event in both layer II/III and layer V neurons of the ipsilateral hem... by Yuanyuan Ji (455424)

“…Note that dendritic branching points (<b>E</b>), dendritic terminal points (<b>F</b>), total dendritic tree length (<b>G</b>), and Sholl intersections (<b>H–J</b>) were all decreased upon MCAO after 24 hours but were fully recovered to values indistinguishable from the corresponding sham controls after 4 days and 7 days reperfusion, respectively. …”

Functional consequences of F-actin binding by Lmod2. by Dávid Szatmári (4510156)

S1 Data - by Ofer N. Gofrit (7833119)

“…Least predictable were pancreatic cancer and chronic myelogenous leukemia (5-year PI of 129, and 42). PI decreased during follow-up in all examined tumors and showed sex differences in some cases. …”

Fig 1 - by Ingmar Lundquist (46422)

General characteristics of the study population. by Chunyang Pang (13264605)

“…Cox proportional hazards models were applied to examine the relationship between retinal markers and incident ALS. Over a median follow-up of 14.11 years, 70 ALS cases occurred among 53,824 participants (incidence 10.58 per 100,000 person-years). …”

Fig 3 - by Ivana R. Sequeira (8309407)

Effects of NNC on sytox, cell scattering and intracellular calcium. by Joseph Schober (4591696)

Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension by Tetsuo Asaki (1366140)